F. Aras Et Al. , "Prognostic Value of TTF-2 and FOXE1 Alterations in Papillary Thyroid Carcinoma: Linking Immunohistochemistry to Genetic Insights," Avrupa Nükleer Tıp Kongresi (EANM) , vol.4, no.247, Vienna, Austria, pp.93-94, 2026
Aras, F. Et Al. 2026. Prognostic Value of TTF-2 and FOXE1 Alterations in Papillary Thyroid Carcinoma: Linking Immunohistochemistry to Genetic Insights. Avrupa Nükleer Tıp Kongresi (EANM) , (Vienna, Austria), 93-94.
Aras, F., Çam, F. S., Tan, A., & Mavili, H. S., (2026). Prognostic Value of TTF-2 and FOXE1 Alterations in Papillary Thyroid Carcinoma: Linking Immunohistochemistry to Genetic Insights . Avrupa Nükleer Tıp Kongresi (EANM) (pp.93-94). Vienna, Austria
Aras, FERAY Et Al. "Prognostic Value of TTF-2 and FOXE1 Alterations in Papillary Thyroid Carcinoma: Linking Immunohistochemistry to Genetic Insights," Avrupa Nükleer Tıp Kongresi (EANM), Vienna, Austria, 2026
Aras, FERAY Et Al. "Prognostic Value of TTF-2 and FOXE1 Alterations in Papillary Thyroid Carcinoma: Linking Immunohistochemistry to Genetic Insights." Avrupa Nükleer Tıp Kongresi (EANM) , Vienna, Austria, pp.93-94, 2026
Aras, F. Et Al. (2026) . "Prognostic Value of TTF-2 and FOXE1 Alterations in Papillary Thyroid Carcinoma: Linking Immunohistochemistry to Genetic Insights." Avrupa Nükleer Tıp Kongresi (EANM) , Vienna, Austria, pp.93-94.
@conferencepaper{conferencepaper, author={FERAY ARAS Et Al. }, title={Prognostic Value of TTF-2 and FOXE1 Alterations in Papillary Thyroid Carcinoma: Linking Immunohistochemistry to Genetic Insights}, congress name={Avrupa Nükleer Tıp Kongresi (EANM)}, city={Vienna}, country={Austria}, year={2026}, pages={93-94} }